Adlai Nortye (NASDAQ:ANL) Stock Price Up 6.3% – What’s Next?

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL)’s stock price traded up 6.3% on Wednesday . The company traded as high as $14.66 and last traded at $14.61. 67,339 shares traded hands during trading, a decline of 83% from the average daily volume of 397,252 shares. The stock had previously closed at $13.74.

Wall Street Analyst Weigh In

Several brokerages recently commented on ANL. Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a research note on Tuesday, July 14th. Wall Street Zen raised shares of Adlai Nortye from a “hold” rating to a “buy” rating in a report on Saturday, August 22nd. Cantor Fitzgerald initiated coverage on shares of Adlai Nortye in a research report on Monday, June 22nd. They set an “overweight” rating for the company. Oppenheimer initiated coverage on Adlai Nortye in a research note on Thursday, May 28th. They set an “outperform” rating and a $32.00 price target on the stock. Finally, JonesTrading assumed coverage on Adlai Nortye in a report on Thursday, May 14th. They issued a “buy” rating and a $22.00 price target on the stock. Five research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $24.25.

Adlai Nortye Price Performance

The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.65 and a current ratio of 9.55. The firm has a 50 day moving average price of $12.09 and a 200-day moving average price of $11.19.

Insider Transactions at Adlai Nortye

In other Adlai Nortye news, CFO Xiaofeng Ye sold 6,000 shares of Adlai Nortye stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $13.98, for a total transaction of $83,880.00. Following the completion of the transaction, the chief financial officer owned 153,424 shares in the company, valued at approximately $2,144,867.52. The trade was a 3.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of ANL. SmartHarvest Portfolios LLC raised its position in shares of Adlai Nortye by 8.5% during the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after purchasing an additional 1,279 shares during the last quarter. Renaissance Technologies LLC purchased a new position in Adlai Nortye during the first quarter worth $457,000. Affinity Asset Advisors LLC purchased a new position in Adlai Nortye during the first quarter worth $1,140,000. ADAR1 Capital Management LLC acquired a new position in shares of Adlai Nortye in the first quarter worth $816,000. Finally, Boone Capital Management LLC acquired a new position in shares of Adlai Nortye in the second quarter worth $2,971,000. 35.21% of the stock is owned by hedge funds and other institutional investors.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.